Citrapos Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

K citrate

Indications/Uses

Renal tubular acidosis (RTA) w/ Ca stones, hypocitraturic Ca oxalate nephrolithiasis of any etiology & uric acid lithiasis w/ or w/o Ca stones.

Click to view Citrapos detailed prescribing information

Dosage/Direction for Use

Severe hypocitraturia (urinary citrate <150 mg/day) 60 mEq/day (20 mEq tid or 15 mEq qid. Mild-moderate hypocitraturia (>150 mg/day) 30 mEq/day (10 mEq tid).

Click to view Citrapos detailed prescribing information

Overdosage

View Citrapos overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food.

Contraindications

Hyperkalemia; chronic renal failure, uncontrolled DM, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown. K-sparing agent (eg, triamterene, spironolactone or amiloride). Patients suffering from delayed gastric emptying, esophageal compression, intestinal obstruction or stricture or those taking anticholinergics; PUD. Renal insufficiency (GFR <0.7 mL/kg/min).

Click to view Citrapos detailed prescribing information

Special Precautions

Patients w/ impaired mechanisms for excreting K, severe myocardial damage or heart failure. Concomitant administration w/ K-sparing diuretic (eg, triamterene, spironolactone or amiloride). Discontinue if severe vomiting, abdominal pain or GI bleeding occurs. Pregnancy & lactation. Childn.

Click to view Citrapos detailed prescribing information

Use In Pregnancy & Lactation

Click to view Citrapos detailed prescribing information

Adverse Reactions

Minor GI complaints eg, abdominal discomfort, vomiting, diarrhea, loose bowel movements or nausea. Intact matrices in feces.

Click to view Citrapos detailed prescribing information

Drug Interactions

May produce severe hyperkalemia w/ K-sparing diuretic (eg, triamterene, spironolactone or amiloride).

Click to view Citrapos detailed prescribing information

Storage

View Citrapos storage conditions for details to ensure optimal shelf-life.

Description

View Citrapos description for details of the chemical structure and excipients (inactive components).

Action

View Citrapos mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Drugs Acting on the Genito-Urinary System

ATC Classification

A12BA02 - potassium citrate ; Belongs to the class of potassium-containing preparations. Used as dietary supplements.

Regulatory Classification

Presentation/Packing

Form

Citrapos ER tab 1,080 mg

Packing/Price

30's

Citrapos

potassium citrate

Manufacturer:

Cooper Pharma

Distributor:

Corbridge

Marketer:

Ambica